Original Publication Date: 1 October, 2016
Publication / Source: Immunotherapy
Authors: Lucia Signorini, Serena Delbue, Pasquale Ferrante & Marco Bregni
Colorectal cancer (CRC) is one of the most common malignancies throughout the world and the leading cause of cancer-related mortality in Western countries. Recent progress in CRC treatment options, such as surgery, chemotherapy, radiotherapy and target therapy, has improved the prognosis, but advanced disease with recurrence or distant metastasis is usually incurable and has an unfavorable prognosis.